Source: EIN Presswire

Press Release: InSphero : InSphero Partners with Chayon to Bring Advanced 3D In Vitro Technologies to South Korean Researchers

InSphero has partnered with Seoul-based Chayon to provide 3D in vitro solutions for drug development to South Korean researchers. SCHLIEREN, SWITZERLAND, November 4, 2024 /⁨EINPresswire.com⁩/ -- InSphero, the pioneer in 3D cell culture and organ-on-chip ...

Read full article »

InSphero's Competitors | InSphero's News | InSphero's Financials

Followers on Owler

139

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Co-Founder & CEO

Jan Lichtenberg

CEO Approval Rating

98/100

InSphero is a Switzerland-based medical technology firm that develops 3D-cell-based assays and 3D organ-on-a-chip products for pharmaceutical and biotechnology researchers.